herkamide

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: herkamide
• 英文别名: (2S,4HR,6aR,7R,9S,10aS,10bR)-9-(benzoylamino)-2-(3-furanyl)-dodecahydro-6a,10b-dimethyI-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester；(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(Benzoylamino)-2-(3-furanyl)-dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester；methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-benzamido-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate
• 化学式: C₂₈H₃₁NO₇
• 分子量: 493.557
• InChiKey: VDVSNRVCSRXZED-XAGHGKQISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  36
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  112
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-aminosalvinorin 、 苯甲酰氯 在 4-二甲氨基吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以67%的产率得到herkamide
  参考文献：
  名称：

  Opioid receptor ligands and methods for their preparation

  摘要：

  该发明提供了公式I的新化合物，这些化合物是阿片受体配体。该发明还提供了包含这些化合物的药物组合物，以及通过向需要治疗的哺乳动物施用这些化合物来治疗与阿片受体功能相关的疾病的方法。该发明还提供了一种改进的方法，用于分离中间体材料，以获得公式I的化合物。

  公开号：

  US20060058264A1

文献信息

• AGONISTS OF THE MU OPIOID RECEPTOR
  申请人：University of Kansas

  公开号：US20170313692A1

  公开（公告）日：2017-11-02

  The present technology is directed to compounds, compositions, and methods related to non-morphinan-like mu opioid receptor agonists. Compounds of the present technology demonstrate remarkable potency and selectivity for the mu opioid receptor over the kappa opioid receptor, while also exhibiting a significant reduction (or, essentially, absence) of the negative side effects of many morphine-derived compounds.

  本技术涉及非吗啡样mu阿片受体激动剂的化合物、组合物和方法。本技术的化合物在mu阿片受体上表现出显著的效力和选择性，而在kappa阿片受体上也表现出显著的选择性，同时还展示出许多吗啡衍生化合物的负面副作用明显减少（或基本上消失）的特点。
• Herkinorin Analogues with Differential β-Arrestin-2 Interactions
  作者：Kevin Tidgewell、Chad E. Groer、Wayne W. Harding、Anthony Lozama、Matthew Schmidt、Alfred Marquam、Jessica Hiemstra、John S. Partilla、Christina M. Dersch、Richard B. Rothman、Laura M. Bohn、Thomas E. Prisinzano

  DOI：10.1021/jm701162g

  日期：2008.4.1

  Salvinorin A is a psychoactive natural product that has been found to be a potent and selective kappa opioid receptor agonist in vitro and in vivo. The activity of salvinorin A is unusual compared to other opioids such as morphine in that it mediates potent kappa opioid receptor signaling yet leads to less receptor downregulation than observed with other kappa agonists. Our initial chemical modifications of salvinorin A have yielded one analogue, herkinorin (1c), with high affinity at the mu OR. We recently reported that 1c does not promote the recruitment of beta-arrestin-2 to the mu OR or receptor internalization. Here we describe three new derivatives of 1c (3c, 3f, and 3i) with similar properties and one, benzamide 7b, that promotes recruitment of beta-arrestin-2 to the mu OR and receptor internalization. When the important role mu opioid receptor regulation plays in determining physiological responsiveness to opioid narcotics is considered,mu opioids derived from salvinorin A may offer a unique template for the development of functionally selective mu opioid receptor-ligands with the ability to produce analgesia while limiting adverse side effects.
• WO2006/138589
  申请人：——

  公开号：——

  公开（公告）日：——
• US7728001B2
  申请人：——

  公开号：US7728001B2

  公开（公告）日：2010-06-01